For: | 冯晓峰, 郑永志, 周春柳, 孔祥毓, 李淑德, 孙卫东. 重组人p53腺病毒注射液在原发性肝癌介入化疗中的应用价值. 世界华人消化杂志 2013; 21(15): 1437-1441 [DOI: 10.11569/wcjd.v21.i15.1437] |
---|---|
URL: | https://www.wjgnet.com/1009-3079/full/v21/i15/1437.htm |
编号 | Citing Articles |
1 |
Wei-Wei Zhang, Longjiang Li, Dinggang Li, Jiliang Liu, Xiuqin Li, Wei Li, Xiaolong Xu, Michael J. Zhang, Lois A. Chandler, Hong Lin, Aiguo Hu, Wei Xu, Dominic Man-Kit Lam. The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the Clinic. Human Gene Therapy 2018; 29(2): 160 doi: 10.1089/hum.2017.218
|
2 |
Yu Xia, Xiuqin Li, Wei Sun. Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China. Current Gene Therapy 2020; 20(2): 127 doi: 10.2174/1566523220999200731003206
|